Month: April 2025
First Quarter 2025 Performance and Operational HighlightsNet income of $10.4 million, or $1.03 per diluted share
Core net income(1) of $10.3 million, or $1.03 per diluted share(1)
Pretax pre-provision core net income(1) of $14.2 million
Net interest income of $24.9 million, a decrease of $171,000 from the prior quarter
Net interest margin (“NIM”) of 3.75%, up 9 basis points from the prior quarter
Return on average assets (“ROAA”) of 1.48%; return on average stockholders’ equity (“ROAE”) of 14.67%; and return on average tangible common equity (“ROATCE”)(1) of 17.19%
Core ROAA(1) of 1.47%; and core ROATCE(1) of 17.16%
Efficiency ratio of 46.42%
Linked-quarter loans grew 6.1% annualized
Linked-quarter deposits grew 2.4% annualized(1) See “Reconciliation of Non-GAAP Financial Measures” below for reconciliation of non-GAAP financial...
IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting
Written by Customer Service on . Posted in Public Companies.
Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented
Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 following alignment on protocol with FDA
LAWRENCEVILLE, N.J., April 21, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting new, highly encouraging, Overall Survival data from the Phase 2 OVATION 2 Study of IMNN-001 to treat women with newly diagnosed advanced ovarian cancer was accepted for oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting is being held May 30 – June 3, 2025, in Chicago, Illinois and virtually. IMUNON recently announced alignment...
Dragonfly Energy Partners with the National Forest Foundation to Plant Thousands of Trees for Earth Day
Written by Customer Service on . Posted in Public Companies.
Dragonfly Energy’s collaboration with the National Forest Foundation underscores the company’s continued commitment to sustainability and environmental stewardship. The pledge from Dragonfly Energy to plant thousands of trees is part of a bigger environmental plan initiated by the US Forest Service to combat climate change.
Dragonfly Energy is committed to helping the National Forest Foundation reach its goal to successfully plant 50 million trees by the end of 2025.RENO, Nev., April 21, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in green energy storage and maker of Battle Born Batteries®, in recognition of Earth Day, is pledging to plant thousands of trees through a collaboration with the National Forest Foundation (NFF), the official non-profit...
BULGOLD Announces Filing of Fourth Quarter Financial Results for Three and Twelve Months Ended December 31, 2024
Written by Customer Service on . Posted in Public Companies.
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) — BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that it has filed its audited annual financial statements and MD&A for the year ended December 31, 2024. For the year ending December 31, 2024, the company incurred a net comprehensive loss of $642,831 ($0.02 per share). On December 31, 2024, the company had cash (and cash equivalents) of $345,204.
About BULGOLD Inc. BULGOLD is a gold exploration company focused on the exploration and development of mineral exploration projects in Central and Eastern Europe. The Company controls 100% of three quality quartz-adularia epithermal gold projects located in the Bulgarian and Slovak portions of the Western Tethyan Belt: the Lutila Gold Project, the Kostilkovo Gold Project and the Kutel Gold Project. Management...
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East
Written by Customer Service on . Posted in Public Companies.
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that Marwan Noel Sabbagh, MD, Professor of Neurology at Barrow Neurological Institute and Chairman of Anavex’s Scientific Advisory Board gave an oral presentation titled, “Oral Blarcamesine Novel Mechanism for Alzheimer Disease: Autophagy Restoration through Upstream SIGMAR1 Activation Clinical Efficacy Phase IIb/III Trial” at the 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle...
Nano Dimension Provides Update on Desktop Metal
Written by Customer Service on . Posted in Public Companies.
Waltham, Massachusetts, April 21, 2025 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today provided an update on Desktop Metal.
Desktop Metal, a subsidiary of Nano Dimension, has commenced a process to explore all available strategic alternatives to address its liabilities and liquidity needs. Desktop Metal has appointed Robert Warshauer to its Board of Directors and engaged Piper Sandler & Co. and FTI Consulting, Inc. as financial advisers.
No assurances can be given as to the outcome or timing of the strategic review process. Nano Dimension plans to share additional details during its upcoming 2024 financial results and 2025 outlook call, expected to be held in late April 2025.
About Nano Dimension
Driven by strong trends in onshoring,...
American Tungsten Corp. to Participate at Top Shelf Partners Commodities Global Expo 2025
Written by Customer Service on . Posted in Public Companies.
Vancouver, BC, April 21, 2025 (GLOBE NEWSWIRE) — American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce its attendance and participation at Top Shelf Partners Commodities Global Expo 2025. The event will take place on May 11th – 13th, 2025, at the Four Seasons in Fort Lauderdale, Florida, U.S., and will focus on connecting key institutional investors with companies supporting critical minerals supply chain resilience and global security, particularly from a U.S. perspective.American Tungsten’s participation in the event underscores the Company’s commitment to advancing dialogue around the importance of securing domestic production capabilities for critical minerals in the United States and its continued long-term strategic plans to advance its flagship tungsten...
Zevra Files Definitive Proxy Statement and Mails Letter to Stockholders
Written by Customer Service on . Posted in Public Companies.
Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management Team
Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and Significant Financial Flexibility to Execute Strategic Plan
Urges Stockholders to Defend Board Independence from Majority Influence by Individual 2.8% Stockholder, Mangless, Who Had Three Nominees Elected to the Board in 2023
Mangless Has Not Detailed any Strategies, Plans, or New Ideas to Improve Zevra’s Business and Appears Solely Focused on Replacing Two Highly Qualified Directors
Board and Management Urge Stockholders to Vote “FOR” Zevra’s Highly-Qualified and Experienced Director Nominees on the WHITE Proxy Card
CELEBRATION, Fla., April 21, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS:...
PX Energy, an Expanding Vertically Integrated Refinery and Mining Operation Located in Southern Brazil, Intends to Go Public Through a Business Combination with Papaya Growth Opportunity Corp. I, Including a Committed $10 Million Investment
Written by Customer Service on . Posted in Mergers And Acquisitions.
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) — PX Energy (“PX” or the “Company”), a vertically-integrated refined products manufacturer serving the Brazilian market for refined oil and agricultural grade products (through its parent company, Forbes & Manhattan Resources Inc.), and Papaya Growth Opportunity Corp. I (“PPYA”) announced today that they have entered into a definitive business combination agreement (the “BCA” and the transactions contemplated under the BCA, the “Business Combination” or the “Transaction”). Upon the completion of the Business Combination, the combined company will retain its name “PX Energy” and its headquarters in Brazil, and its ordinary shares to be listed on Nasdaq. PX Energy website is located at: https://pxenergy.com.brPhotograph of the PXenergy refinery facilities located in Parana State, BrazilPX...
BioStem Technologies to Present at the Centri Capital Conference
Written by Customer Service on . Posted in Public Companies.
The presentation will be webcast at 10:30 AM ET on April 22, 2025
POMPANO BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, is pleased to announce that its Chief Executive Officer, Jason Matuszewski, will be presenting and holding one-on-one meetings at the upcoming Centri Capital Conference on April 22, 2025, taking place at the Nasdaq headquarters in New York City.
BioStem Technologies Presentation Access:Presenter: Jason Matuszewski, Chief Executive Officer
Date: Tuesday, April 22, 2025
Time: 10:30 AM ET
Webcast Link & Archive: HERE
1-on-1 Meeting Request: adam@holdsworthco.comJoin BioStem’s Distribution List & Social Media:To follow...
